L Patrick Gage becomes chair of Tetraphase board
This article was originally published in Scrip
Clinical stage tetracycline antibiotics developer, Tetraphase, has appointed Dr L Patrick Gage chair of its board of directors. Dr Gage currently serves on the boards of several life science companies, including as chair of Cytokinetics. He served as president of research at Wyeth/American Home Products Corporation until 2002.